ClinStar Director Business Development Michael Sullivan to Co-Lead Pre-Conference Workshop at Marcus Evans 7th Annual Clinical Research in Emerging Countries Conference
ClinStar to Co-Host Roundtable Discussion on Optimizing Site Selection in Emerging Markets for Global Clinical Trials
<0> ClinStar LLCHeather Newbold, 919-354-3573 ext. 276Associate Director, Marketing </0>
, an established clinical research organization providing clinical research services in the emerging markets of Russia and Eastern Europe to the biopharmaceutical industry, announced today that Director Business Development Michael Sullivan will co-lead a pre-conference workshop entitled, “Improving Global Clinical Strategies and Evaluating Key Criteria for Optimum Site Selection in Emerging Countries” at , August 14-16, at The Rittenhouse Hotel, Philadelphia, PA.
“The pharmaceutical and biotechnology industry is facing surmounting pressure to be innovative and replenish thinning drug pipelines while operating under lean research budgets and dealing with the largest patent cliff in drug development history,” says Mr. Sullivan. “With investigator sites saturated in the West, the lure of large, untapped patient populations, faster enrollment rates and lower drop-out rates in emerging markets can no longer be ignored.”
During the workshop scheduled for Tuesday, August 14, 2012 at 1:30 p.m., Mr. Sullivan will draw upon his 10+ years in clinical outsourcing and program management with BMS and his current role with ClinStar helping companies realize the benefits of outsourcing to Russia and parts of Eastern Europe to co-lead a round-table discussion. Key considerations will be given to benefits and challenges of site selection in emerging markets and best strategies to ensure clinical trial quality while minimizing timelines.
ClinStar is one of the most prominent clinical research organizations in the emerging markets of Eastern Europe and the Baltics with more than 10 years of expertise in Phase I-IV clinical research studies in multiple therapeutic areas. Headquartered in San Francisco, California, ClinStar manages studies from its offices in Russia, Ukraine and Belarus, with total staff of over 260 people. Its portfolio contains over 130 clinical trials conducted for US and European pharmaceutical and biotechnology companies. More information is available at .